Identification of patients with coronary disease at high risk for loss of employment. A prospective validation study

D B Mark1, L C Lam, K L Lee

  • 1Division of Cardiology, Duke University Medical Center, Durham, N.C. 27710.

Circulation
|November 1, 1992
PubMed

Insights

Coronary artery disease patients at high risk for leaving the workforce can be identified using a model combining medical and non-medical factors. Revascularization alone does not ensure return to work.

Area of Science:

  • Cardiology
  • Occupational Health
  • Health Economics

Background:

  • Work disability is prevalent in coronary artery disease (CAD) patients, impacting their economic well-being and quality of life.
  • Predicting premature workforce departure in CAD patients is crucial for targeted interventions.

Purpose of the Study:

  • To develop and prospectively validate a predictive model for premature work force departure in patients with coronary disease.

Main Methods:

  • A cohort of 1,252 employed CAD patients under 65 were assessed for medical, functional, psychological, economic, and job-related variables.
  • Logistic regression was used to build a multivariable model, validated in an independent cohort.
  • Patients were followed for 1 year to determine work status.

Main Results:

  • Eight factors independently predicted work force departure: lower functional status, older age, black race, congestive heart failure, lower education, extracardiac vascular disease, poorer psychological status, and lower job classification.
  • Functional, demographic, and socioeconomic measures were more informative than standard clinical variables.
  • The model demonstrated good predictive accuracy in both training (0.80) and test (0.74) samples.

Conclusions:

  • A combination of medical and non-medical factors accurately identifies CAD patients at high risk for premature work force exit.
  • The developed model serves as a tool for identifying at-risk individuals who may benefit from multidimensional intervention programs.
  • Revascularization procedures (PTCA or CABG) alone are insufficient to maintain work status.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...